Wellington Management Group LLP Has $1.77 Million Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Wellington Management Group LLP lessened its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 74.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 22,604 shares of the company's stock after selling 65,354 shares during the period. Wellington Management Group LLP's holdings in Prestige Consumer Healthcare were worth $1,765,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the business. Kestra Investment Management LLC acquired a new position in Prestige Consumer Healthcare during the 4th quarter valued at about $27,000. CIBC Private Wealth Group LLC lifted its position in shares of Prestige Consumer Healthcare by 48.9% in the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock valued at $34,000 after acquiring an additional 152 shares in the last quarter. Headlands Technologies LLC purchased a new stake in shares of Prestige Consumer Healthcare in the 4th quarter valued at approximately $40,000. McIlrath & Eck LLC lifted its position in shares of Prestige Consumer Healthcare by 19.1% in the 4th quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock valued at $75,000 after acquiring an additional 154 shares in the last quarter. Finally, Johnson Financial Group Inc. acquired a new position in Prestige Consumer Healthcare in the 4th quarter valued at approximately $93,000. Institutional investors own 99.95% of the company's stock.

Prestige Consumer Healthcare Price Performance

Shares of NYSE:PBH traded up $0.49 during midday trading on Friday, reaching $85.11. 189,224 shares of the company's stock were exchanged, compared to its average volume of 299,912. Prestige Consumer Healthcare Inc. has a 12 month low of $63.79 and a 12 month high of $90.04. The firm has a market capitalization of $4.21 billion, a PE ratio of 19.93, a price-to-earnings-growth ratio of 2.69 and a beta of 0.45. The company's 50 day simple moving average is $83.53 and its two-hundred day simple moving average is $82.52. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.30 by $0.02. The firm had revenue of $296.52 million during the quarter, compared to the consensus estimate of $289.36 million. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. The firm's quarterly revenue was up 7.0% on a year-over-year basis. During the same period last year, the firm posted $1.02 EPS. Equities research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

PBH has been the topic of several research reports. Wall Street Zen upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, May 17th. Royal Bank of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Finally, Oppenheimer increased their price target on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a report on Thursday, February 13th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, Prestige Consumer Healthcare currently has an average rating of "Moderate Buy" and a consensus price target of $93.33.

Insider Buying and Selling at Prestige Consumer Healthcare

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of the firm's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $90.00, for a total value of $151,020.00. Following the completion of the sale, the senior vice president now owns 17,157 shares in the company, valued at approximately $1,544,130. This trade represents a 8.91% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.60% of the company's stock.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.